| Hollie Thomas, | |
|
310 Autumn Ridge Dr, Kosciusko, MS 39090-3242 | |
| (662) 289-3499 | |
| Not Available |
| Full Name | Hollie Thomas |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 310 Autumn Ridge Dr, Kosciusko, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487093993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | S3747 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hollie Thomas, 4109 Highway 98 W, Summit, MS 39666-9132 Ph: () - | Hollie Thomas, 310 Autumn Ridge Dr, Kosciusko, MS 39090-3242 Ph: (662) 289-3499 |
News Archive
The billions of bugs in our guts have a newfound role: regulating the immune system and related autoimmune diseases such as rheumatoid arthritis, according to researchers at Mayo Clinic and the University of Illinois at Urbana-Champaign.
Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery, biomarker development and aging research, is pleased to announce the presentation of its Director of Drug Discovery, Dr. Ivan Ozerov, at the 24th Clinical Applications for Age Management Medicine Conference, April 27, 2018, organized by Age Management Medicine Group.
People with heart disease can receive either the high-dose or standard-dose flu vaccines for protection from heart or lung-related deaths or hospitalizations, according to late breaking research presented today at the American Heart Association's Scientific Sessions 2020.
Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients' ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women's Cancer Center investigators shows.
Principio Inc., a privately held emerging company developing novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, today announced that the Company has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
› Verified 7 days ago
Karla Barrentine Tate, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3067 Attala Road 2247, Kosciusko, MS 39090 Phone: 601-953-2920 | |
Ashley Wilkerson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Autumn Ridge Dr, Kosciusko, MS 39090 Phone: 662-289-3499 | |
Sharhonda Wingo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2447 Attala Road 2203, Kosciusko, MS 39090 Phone: 662-435-0504 | |
Ms. Courtney Fletcher, M.S.,SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Wildwood Ter, Kosciusko, MS 39090 Phone: 662-582-0786 | |
Ms. Whitney Moore Pettit, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Parkway Plz, Kosciusko, MS 39090 Phone: 662-289-3588 | |
Whitney Jones, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 Autumn Ridge Dr, Kosciusko, MS 39090 Phone: 662-289-3499 |